Every claim we hold, and how far we can stand behind it.
142 claims across 39 products. 28% are confirmed against the source text by the evidence gate; 39% come from a class with no vendor interest. Everything below is browsable, filterable, and available as JSON.
| Evidence class | Claims | Confirmed | What it can support |
|---|---|---|---|
| Peer-reviewed study | 19 | 5 | Reviewed before publication; assess study quality, funding, conflicts, and relevance to your setting. |
| Regulatory filing | 4 | 0 | A statement made to a regulator, where being wrong has consequences. |
| Independent report | 32 | 9 | Reporting outside a vendor publication; assess underlying data, sponsorship, and conflicts separately. |
| Customer case | 4 | 3 | A real deployment, but selected and framed by someone with an interest. |
| Press release | 63 | 22 | The vendor's own announcement. Useful for dates and facts, not for outcomes. |
| Vendor page | 20 | 1 | Marketing copy. Establishes what is claimed, never that it is true. |
Showing 2 of 2 matching claims (142 in the full corpus) · 0% of this selection is confirmed · clear filters
Prospective multi-centre study (Open Forum Infectious Diseases, 2026) of qXR version 3 AI-based chest X-ray screening across 3 public health facilities in Chhattisgarh, India: of 2,745 CXRs screened, 363 patients were presumptive for TB and 162 confirmed cases were found (44.63% positivity among presumptive cases), and an 80.21% increase in TB case notifications was observed during the AI-implemented period versus baseline (P < .001).
Provenance
- Claim ID
- clm_326a114cde5f51400f91
- Version
- 1
- Workflow
- Imaging & Diagnostic AI
- Dimension
- evidence strength
- Retrieved
- 2026-08-27
- Reviewer
- healthit-gate-v1
- Source URL
- https://pmc.ncbi.nlm.nih.gov/articles/PMC12810203/
Multi-country head-to-head accuracy comparison (Annals of the American Thoracic Society, 2026) of 7 automated chest X-ray algorithms on 3,901 chest X-rays from India, Madagascar, the Philippines, South Africa, Tanzania, Uganda, and Vietnam found qXR achieved the WHO minimum target accuracy for a tuberculosis triage test (>=90% sensitivity with >=70% specificity), with specificity of 70% or greater at 90% sensitivity.
Provenance
- Claim ID
- clm_36833a1aa15ec821791a
- Version
- 1
- Workflow
- Imaging & Diagnostic AI
- Dimension
- evidence strength
- Retrieved
- 2026-08-27
- Reviewer
- healthit-gate-v1
- Source URL
- https://doi.org/10.1093/annalsats/aaoag011